The study on Sedline spectrum changes of induced anterograde amnesia with different anesthetics

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100046799

Enrollment

Unknown

Registered

2021-05-28

Start date

2021-06-01

Completion date

Unknown

Last updated

2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanisms of general anesthesia

Interventions

Saline group:Inject normal saline

Midazolam group:Inject midazolam

Propofol group:Inject propofol

Dexamethasone group:Inject dexamethasone

Etomidate group:Inject etomidate

Eskatamine group:Inject eskatamine

Sevoflurane group:Inject sevoflurane

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 18 to 75 years; 2.Both male and female; 3.ASA grade I-III; 4.Patients who can communicate normally.

Exclusion criteria

Exclusion criteria: 1.Allergic to any anesthetic involved in this trial; 2.History of mental disease; 3.Already recruited in other clinical trials.

Design outcomes

Primary

Measure	Time frame
State-trait anxiety inventory;Sleep quality scale;Mini-mental status examination;Delirium assessment method scale;Bruggrmann comfort scale;Sedline power spectrum;Alertness/sedation score;Pain score;	—

Countries

China

Contacts

Public ContactZheng Kang

Zhongda Hospital, Southeast University

13327819101@163.com+86 13327819101

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026